Screener
Ginkgo Bioworks DNA Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
FAQ
- What is Ginkgo Bioworks's total equity?
- Ginkgo Bioworks (DNA) reported total equity of $420.28M in Q2 2026.
- How has Ginkgo Bioworks's total equity changed year-over-year?
- Ginkgo Bioworks's total equity decreased by 31.4% year-over-year, from $612.95M to $420.28M.
- What is the long-term trend for Ginkgo Bioworks's total equity?
- Over 5 years (2020 to 2025), Ginkgo Bioworks's total equity has grown at a 2.0% compound annual growth rate (CAGR), from $461.38M to $508.59M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Ginkgo Bioworks's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude